2-Pyrrolidone

2-Pyrrolidone

SCHEMBL4367304

Br.O=C1CCCN1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of 2-Pyrrolidone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Pyrrolidone SCHEMBL1048019 1.00 OR51E2 (0.94)
2-Pyrrolidone SCHEMBL511486 1.00
2-Pyrrolidone SCHEMBL28877688 0.97
2-Pyrrolidone SCHEMBL28933712 0.97
2-Pyrrolidone SCHEMBL9441874 0.97
2-Pyrrolidone SCHEMBL27827832 0.97
2-Pyrrolidone SCHEMBL4299593 0.97
2-Pyrrolidone SCHEMBL9304498 0.97 OR51E2 (1.00)
2-Pyrrolidone SCHEMBL2389 0.97
2-Pyrrolidone SCHEMBL2167448 0.97 OR51E2 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698516-A1 PYRROLIDINONE UREA FPR2 AGONISTS Bristol-Myers Squibb Company (US) 2026-02-25 EP disclosed
US-20240409533-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2024-12-12 US disclosed
CN-113874074-B HMOX1 inducers 米托布里奇公司 2024-11-01 CN disclosed
WO-2024220453-A1 PYRROLIDINONE UREA FPR2 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2024-10-24 WO disclosed
US-12071433-B2 HMOX1 inducers Astellas Engineered Small Molecules US, Incorporated (US) 2024-08-27 US disclosed
US-20240051952-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2024-02-15 US disclosed
US-20220177460-A1 HMOX1 INDUCERS Astellas Engineered Small Molecules US, Incorporated 2022-06-09 US disclosed
EP-3952990-A1 HMOX1 INDUCERS Mitobridge, Inc. (US) 2022-02-16 EP disclosed
CN-113874074-A HMOX1 inducers 米托布里奇公司 2021-12-31 CN disclosed
WO-2020210339-A1 HMOX1 INDUCERS MITOBRIDGE, INC. (US) 2020-10-15 WO disclosed
US-4493836-A HYPOTENSIVE, ANTISEROTONINE AGENTS, DOPAMINE ANTAGONIST Uclaf, Roussel (FR) 1985-01-15 US disclosed
EP-0102540-A2 Beta-triazolyl ketals, process for their preparation and fungicides containing them BASF Aktiengesellschaft (DE) 1984-03-14 EP disclosed
EP-0102543-A2 Dioxanylazol derivatives, fungicides containing them and their use as fungicides BASF Aktiengesellschaft (DE) 1984-03-14 EP disclosed
US-4385925-A 1,3-Dioxan-5-yl-alkyltriazoles, their preparation, their use for regulating plant growth, and regulators containing these compounds BASF AKTIENGESELLSCHAFT (DE) 1983-05-31 US disclosed
US-4368066-A 1,3-Dioxan-5-yl-alkenyltriazoles, their preparation, their uses in regulating plant growth, and regulators containing these compounds BASF AKTIENGESELLSCHAFT (DE) 1983-01-11 US disclosed
EP-0062236-A2 Use of triazole derivatives for combating fungi BASF Aktiengesellschaft (DE) 1982-10-13 EP disclosed
US-4318910-A Indolobenzoxazines ROUSSEL UCLAF (FR) 1982-03-09 US disclosed
EP-0044407-A2 1,3-Dioxan-5-yl-alkyl triazoles, their preparation and their use as plant growth regulators BASF Aktiengesellschaft (DE) 1982-01-27 EP disclosed
EP-0043923-A2 1,3-Dioxan-5-yl-alkenyl triazoles, their preparation and their use as plant growth regulators BASF Aktiengesellschaft (DE) 1982-01-20 EP disclosed
US-4041064-A PROSTAGLANDINS; ANTISPASMODICS, ISOTONICS, ANTIASTHMATICS, ANTIULCER AND ANTISECRETORY AGENTS CARLO-ERBA S.P.A. (IT) 1977-08-09 US disclosed